Children's Intensive Research-Residency Program (CHIRRP)
Approved by the American Board of Pediatrics (ABP), CHIRRP is designed for residents who have earned an MD (with substantial research experience) or MD/PhD and are committed to an academic research career. The ABP's Integrated Research Pathway allows for 11 months of research to be integrated into three years of general pediatrics residency prior to entering a three-year fellowship in a pediatric subspecialty.
Residents parallel traditional clinical residency for most of the first year. They spend 11 months out of the three-year residency in research training opportunities. Research training months are maximized in the final two years of residency. Continuity clinic continues weekly throughout the three years.
Mentorship is a central feature of our program. We assemble a customized mentoring committee for each resident and a research mentor is identified based on the applicant's experience and career interests, which may be oriented toward basic science, clinical science, public health, or health policy.
Research residents are selected by the same residency match system in place for traditional applicants. One to two research-residency slots are offered annually. Intern applicants cannot be guaranteed acceptance into CHIRRP prior to the beginning of their internship since clinical performance and PL-1 in-service exam scores are used to judge a candidate's suitability for this training.
House staff who wish to pursue this pathway must notify the Program Directors by January 1 of the internship year.
Necessary requirements to be considered include:
- Extensive prior research experience (most will have graduate degrees in addition to their medical degree) and/or evidence of a sustained research effort.
- Indication, from the candidate's PL-1 in-training exam score, that he or she will probably be able to pass the American Board of Pediatrics Certifying Exam without a third year of general pediatric clinical training.
- Candidates must be approved by the ABP during the first nine months of the PL-1 year.
An Massaro, MD
CHIRRP Steering Committee
Robert Freishtat, MD, MPH (Translational Science)
Brian Rood, MD (Cancer)
Adeline Vanderver, MD (Neuroscience)